Photo by atikahakhtar from unsplash
Several papers reported that tumor necrosis factor (TNF)-α inhibitors such as adalimumab (ADA) induced interstitial pneumonia (IP) in patients with rheumatoid arthritis1-3 . We here retrospectively investigated the changes in… Click to show full abstract
Several papers reported that tumor necrosis factor (TNF)-α inhibitors such as adalimumab (ADA) induced interstitial pneumonia (IP) in patients with rheumatoid arthritis1-3 . We here retrospectively investigated the changes in serum KL-6 levels, which should be elevated in patient with IP4 , in psoriasis patients receiving secukinumab (SEC), anti-interleukin (IL)-17A antibody, in addition to patients receiving ADA. This article is protected by copyright. All rights reserved.
Keywords:
secukinumab decreases;
serum krebs;
level;
decreases serum;
psoriasis;
krebs von
Journal Title: British Journal of Dermatology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: British Journal of Dermatology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!